Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023311
Filing Date
2017-11-09
Accepted
2017-11-09 16:52:14
Documents
88
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20170930.htm 10-Q 1762387
2 EX-10.3 reph-ex103_325.htm EX-10.3 135360
3 EX-31.1 reph-ex311_7.htm EX-31.1 17436
4 EX-31.2 reph-ex312_13.htm EX-31.2 17283
5 EX-31.3 reph-ex313_9.htm EX-31.3 17276
6 EX-32.1 reph-ex321_11.htm EX-32.1 9552
  Complete submission text file 0001564590-17-023311.txt   8284953

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT reph-20170930.xml EX-101.INS 1911546
8 XBRL TAXONOMY EXTENSION SCHEMA reph-20170930.xsd EX-101.SCH 62344
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20170930_cal.xml EX-101.CAL 57356
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20170930_def.xml EX-101.DEF 225676
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20170930_lab.xml EX-101.LAB 483456
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20170930_pre.xml EX-101.PRE 397879
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 171191602
SIC: 2834 Pharmaceutical Preparations